Common Shares of Beneficial Interest of Bitwise Avalanche ETF (BAVA)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Bavarian Nordic's IMVANEX(r) Smallpox Vaccine Receives Positive Opinion From European Regulatory Authorities

KVISTGAARD, Denmark, May 31, 2013 (GLOBE NEWSWIRE) -- Bavarian Nordic A/S (OMX:BAVA) announced today that the Committee for Medicinal Products...

Bavarian Nordic Establishes a Sponsored Level 1 ADR Program in the US

KVISTGAARD, Denmark, May 29, 2013 (GLOBE NEWSWIRE) -- Bavarian Nordic A/S (OMX:BAVA) announced today that it has established a sponsored Level 1...

Bavarian Nordic's CV-301 Cancer Immunotherapy Candidate Shows Promise in Colorectal Cancer

MOUNTAIN VIEW, Calif., May 29, 2013 (GLOBE NEWSWIRE) -- Bavarian Nordic (OMX:BAVA) announced today that promising data from a Phase 2 trial of...

Bavarian Nordic Announces Presentation of PROSTVAC(R) at the 2013 ASCO Annual Meeting

KVISTGAARD, Denmark, May 27, 2013 (GLOBE NEWSWIRE) -- Bavarian Nordic A/S (OMX: BAVA) announced today that a new planned trial of PROSTVAC® in...

Bavarian Nordic Reports First Quarter 2013 Results

KVISTGAARD, Denmark, May 16, 2013 (GLOBE NEWSWIRE) -- Bavarian Nordic A/S (OMX:BAVA) today publishes its first quarter 2013 results. Revenue for...

Bavarian Nordic Receives Contract Valued Up to USD 228 Million From the U.S. Government Securing Continued Production and Deliv

KVISTGAARD, Denmark, April 16, 2013 (GLOBE NEWSWIRE) -- Bavarian Nordic A/S (OMX:BAVA) announced today that BARDA (Biomedical Advanced Research...

Bavarian Nordic Agrees on Interim Analysis with the FDA and Provides an Update on its PROSPECT Phase 3 Trial

KVISTGAARD, Denmark, April 8, 2013 (GLOBE NEWSWIRE) -- Bavarian Nordic A/S (OMX: BAVA) today announced that the Company plans to conduct an...

Bavarian Nordic Announces 2012 Full Year Results

KVISTGAARD, Denmark, March 12, 2013 (GLOBE NEWSWIRE) -- Bavarian Nordic A/S (OMX: BAVA) today published its 2012 Annual Report. Revenue was DKK...

Bavarian Nordic Applauds Reauthorization of Key U.S. Biodefense Programs

KVISTGAARD, Denmark, March 5, 2013 (GLOBE NEWSWIRE) -- Bavarian Nordic A/S (NASDAQ OMX: BAVA) today applauded the final passage of the Pandemic...